PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scientists pinpoint protein that could improve small cell lung cancer therapies

Scientists pinpoint protein that could improve small cell lung cancer therapies
2014-04-22
(Press-News.org) Approximately 15 percent of all lung cancers are small cell lung cancers (SCLC), which grow rapidly and often develop resistance to chemotherapy. However, researchers at Virginia Commonwealth University Massey Cancer Center have revealed new insights into the mechanisms leading to this resistance that may lead to improved therapies.

Chemotherapies work primarily by mediating B-cell lymphoma 2 (Bcl-2) family proteins, which are responsible for regulating cell death. Depending on their function, this family of proteins can trigger a form of cell suicide known as apoptosis or they can activate mechanisms that prevent apoptosis and promote cell survival. Recently, drugs have been developed that block the function of pro-survival Bcl-2 family proteins. One of these drugs known as ABT-737, and its orally available derivative ABT-263 (currently being tested in clinical trials), has been shown to kill SCLC cells and potentially increase the effectiveness of chemotherapies that affect Bcl-2 family proteins. However, the effectiveness of ABT-737 varies greatly in a broad range of SCLC cells.

In a recent study published in Nature Publishing Group's journal Cell Death & Disease, Massey researchers Hisashi Harada, Ph.D., and Geoffrey Krystal, M.D., Ph.D., discovered that the expression of a protein called Noxa is critical to the effectiveness of ABT-737 because it helps regulate the function of MCL-1, another pro-survival Bcl-2 family protein. Through experiments with cultured SCLC cells, the researchers found that Noxa recruits MCL-1 to the mitochondria, the cell's power producer, which degrades MCL-1 and makes the cancer cells more sensitive to ABT-737.

"Essentially, we discovered how ABT-737 works and why some small cell lung cancer cells are not as affected by it," says Harada, member of the Cancer Cell Signaling research program at Massey and assistant professor in the Philips Institute of Oral and Craniofacial Molecular Biology at the VCU School of Dentistry. "By targeting Noxa, which breaks down MCL-1, we could potentially develop novel small cell lung cancer therapies and help overcome resistance to conventional chemotherapies."

Previous research has shown that Bcl-2 pro-survival family members, like BCL-2 and MCL-1, are over-expressed in SCLC. However, until recently the precise role of these proteins in SCLC biology and therapeutic resistance was poorly understood. When ABT-737 was discovered, it was able to block BCL-2 and another pro-survival protein known as BCL-XL, but not MCL-1. The current research points to the pro-survival functions of MCL-1 as the cause of ABT-737's varied effectiveness.

"Now that we have uncovered Noxa and MCL-1 as potential targets, we can work to better define the mechanisms that help regulate their expression," says Krystal, member of the Developmental Therapeutics research program at Massey, professor of internal medicine in the Division of Hematology, Oncology and Palliative Care and affiliate professor in the Department of Microbiology and Immunology in the VCU School of Medicine, and chair of the Division of Hematology/Oncology at the Hunter Holmes McGuire VA Medical Center. "Moving forward, we plan to conduct additional studies to further define these mechanisms in order to better sensitize small cell lung cancer cells to drugs like ABT-737."

INFORMATION:

Harada and Krystal collaborated on this research with Nobuyuki Tanaka, M.D., Ph.D., professor at the Nippon Medical School in Japan; Wataru Nakajima, Ph.D., Virginia Commonwealth University post-doctoral fellow; and Mark Hicks, research assistant.

This research was supported by a grant from the Massey Cancer Center Pilot Project Program, National Institutes of Health grant R01CA134473 and, in part, by Massey's National Cancer Institute Cancer Center Support Grant P30 CA016059.

The full manuscript of this study is available online at: http://www.nature.com/cddis/journal/v5/n2/pdf/cddis20146a.pdf

News directors: Broadcast access to VCU Massey Cancer Center experts is available through VideoLink ReadyCam. ReadyCam transmits video and audio via fiber optics through a system that is routed to your newsroom. To schedule a live or taped interview, contact Alaina Schneider, (804) 628-4578.

About VCU Massey Cancer Center

VCU Massey Cancer Center is one of only 68 National Cancer Institute-designated institutions in the country that leads and shapes America's cancer research efforts. Working with all kinds of cancers, the Center conducts basic, translational and clinical cancer research, provides state-of-the-art treatments and clinical trials, and promotes cancer prevention and education. Since 1974, Massey has served as an internationally recognized center of excellence. It offers the most cancer clinical trials in Virginia and serves patients at 10 locations. Its 1,000 researchers, clinicians and staff members are dedicated to improving the quality of human life by developing and delivering effective means to prevent, control and ultimately to cure cancer. Visit Massey online at http://www.massey.vcu.edu or call 877-4-MASSEY for more information.

About VCU and the VCU Medical Center

Virginia Commonwealth University is a major, urban public research university with national and international rankings in sponsored research. Located in downtown Richmond, VCU enrolls more than 31,000 students in 222 degree and certificate programs in the arts, sciences and humanities. Sixty-six of the programs are unique in Virginia, many of them crossing the disciplines of VCU's 13 schools and one college. MCV Hospitals and the health sciences schools of Virginia Commonwealth University compose the VCU Medical Center, one of the nation's leading academic medical centers. For more, see http://www.vcu.edu.

[Attachments] See images for this press release:
Scientists pinpoint protein that could improve small cell lung cancer therapies

ELSE PRESS RELEASES FROM THIS DATE:

Risk of pregnancy greater with newer method of female sterilization

2014-04-22
(SACRAMENTO, Calif.) — The risk of pregnancy among women using a newer method of planned sterilization called hysteroscopic sterilization is more than 10 times greater over a 10-year period than using the more commonly performed laparoscopic sterilization, a study by researchers at Yale University and UC Davis has found. Published online today in the medical journal Contraception, the study found the higher risk of pregnancy with a newer sterilization method marketed under the brand name Essure®. "This study provides essential information for women and their doctors ...

PETA science consortium to present hazard testing strategy at nanotoxicology meeting

2014-04-22
London – PETA International Science Consortium Ltd.'s nanotechnology expert will present a poster titled "A tiered-testing strategy for nanomaterial hazard assessment" at the 7th International Nanotoxicology Congress to be held April 23-26, 2014, in Antalya, Turkey. Dr. Monita Sharma will outline a strategy consistent with the 2007 report from the US National Academy of Sciences, "Toxicity Testing in the 21st Century: A Vision and a Strategy," which recommends use of non-animal methods involving human cells and cell lines for mechanistic pathway–based toxicity studies. ...

Nanoreporters tell 'sour' oil from 'sweet'

2014-04-22
Scientists at Rice University have created a nanoscale detector that checks for and reports on the presence of hydrogen sulfide in crude oil and natural gas while they're still in the ground. The nanoreporter is based on nanometer-sized carbon material developed by a consortium of Rice labs led by chemist James Tour and is the subject of a new paper published this month in the American Chemical Society journal ACS Applied Materials and Interfaces. Limited exposure to hydrogen sulfide causes sore throats, shortness of breath and dizziness, according to the researchers. ...

New research focuses on streamwater chemistry, landscape variation

2014-04-22
MISSOULA – Winsor Lowe, interim director of the University of Montana's Wildlife Biology Program, co-wrote a research paper published April 21 in the Proceedings of the National Academy of Sciences on how streamwater chemistry varies across a headwater stream network. Lowe and co-authors from Virginia Tech, the U.S. Geological Survey, the University of Washington, the Cary Institute of Ecosystem Studies, the University of Connecticut and the U.S. Forest Service Northern Research Station examined 664 water samples collected every 10 meters along 32 tributaries ...

Online retailers have clear advantage by not collecting sales tax

2014-04-22
COLUMBUS, Ohio – Two independent studies use two very different approaches to reach the same conclusion: some online retailers really do have an advantage over traditional brick-and-mortar stores. The studies find evidence from investors, analysts and consumers themselves that suggest online stores have a competitive edge when they don't have to collect sales tax from shoppers. Both studies were conducted by researchers at the Fisher College of Business at The Ohio State University and their colleagues. In one study, Brian Baugh, Itzhak Ben-David, and Hoonsuk Park ...

Scientists identify critical new protein complex involved in learning and memory

Scientists identify critical new protein complex involved in learning and memory
2014-04-22
JUPITER, FL, April 22, 2014 – Scientists from the Florida campus of The Scripps Research Institute (TSRI) have identified a protein complex that plays a critical but previously unknown role in learning and memory formation. The study, which showed a novel role for a protein known as RGS7, was published April 22, 2014 in the journal eLife, a publisher supported by the Howard Hughes Medical Institute, the Max Planck Society and the Wellcome Trust. "This is a critical building block that regulates a fundamental process—memory," said Kirill Martemyanov, a TSRI associate ...

Almost one-third of Canadian adults have experienced child abuse

2014-04-22
Almost one-third of adults in Canada have experienced child abuse — physical abuse, sexual abuse or exposure to intimate partner (parents, step-parents or guardians) violence in their home. As well, child abuse is linked to mental disorders and suicidal ideation (thoughts) or suicide attempts, found an article published in CMAJ (Canadian Medical Association Journal). "From a public health standpoint, these findings highlight the urgent need to make prevention of child abuse a priority in Canada," writes Dr. Tracie Afifi, departments of Community Health Sciences and Psychiatry, ...

Multiple sclerosis: A review of current treatments for physicians

2014-04-22
A review of the literature on treating multiple sclerosis (MS) aims to provide physicians with evidence-based information on the latest treatments for this chronic disease. The article, published in CMAJ (Canadian Medical Association Journal) looks at the latest pharmacologic research as well as disease-modifying agents and the benefits and risks of various treatments. "Recently, several new compounds have been developed and approved with the aim of favourably changing the disease course, but with varied success," writes Dr. Loredana La Mantia, Cochrane Multiple Sclerosis ...

Neuroimaging: Live from inside the cell

Neuroimaging: Live from inside the cell
2014-04-22
This news release is available in German. Reactive oxygen species are important intracellular signaling molecules, but their mode of action is complex: In low concentrations they regulate key aspects of cellular function and behavior, while at high concentrations they can cause "oxidative stress", which damages organelles, membranes and DNA. To analyze how redox signaling unfolds in single cells and organelles in real-time, an innovative optical microscopy technique has been developed jointly by the teams of LMU Professor Martin Kerschensteiner and TUM Professor ...

Research shows impact of Facebook unfriending

2014-04-22
DENVER (April 22, 2014) – Two studies from the University of Colorado Denver are shedding new light on the most common type of `friend' to be unfriended on Facebook and their emotional responses to it. The studies, published earlier this year, show that the most likely person to be unfriended is a high school acquaintance. "The most common reason for unfriending someone from high school is that the person posted polarizing comments often about religion or politics," said Christopher Sibona, a doctoral student in the Computer Science and Information Systems program at ...

LAST 30 PRESS RELEASES:

Launch of the most comprehensive, and up to date European Wetland Map

Lurie Children’s campaign urges parents to follow up right away if newborn screening results are abnormal

Does drinking alcohol really take away the blues? It's not what you think

Speed of risk perception is connected to how information is arranged

High-risk pregnancy specialists analyze AI system to detect heart defects on fetal ultrasound exams

‘Altar tent’ discovery puts Islamic art at the heart of medieval Christianity

Policy briefs present approach for understanding prison violence

Early adult mortality is higher than expected in US post-COVID

Recycling lithium-ion batteries cuts emissions and strengthens supply chain

Study offers new hope for relieving chronic pain in dialysis patients

How does the atmosphere affect ocean weather?

Robots get smarter to work in sewers

Speech Accessibility Project data leads to recognition improvements on Microsoft Azure

Tigers in the neighborhood: How India makes room for both tigers and people

Grove School’s Arthur Paul Pedersen publishes critical essay on scientific measurement literacy

Moffitt study finds key biomarker to predict KRASG12C inhibitor effectiveness in lung cancer

Improving blood transfusion monitoring in critical care patients: Insights from diffuse optics

Powerful legal and financial services enable kleptocracy, research shows

Carbon capture from constructed wetlands declines as they age

UCLA-led study establishes link between early side effects from prostate cancer radiation and long-term side effects

Life cycles of some insects adapt well to a changing climate. Others, not so much.

With generative AI, MIT chemists quickly calculate 3D genomic structures

The gut-brain connection in Alzheimer’s unveiled with X-rays

NIH-funded clinical trial will evaluate new dengue therapeutic

Sound is a primary issue in the lives of skateboarders, study shows

Watch what you eat: NFL game advertisements promote foods high in fat, sodium

Red Dress Collection Concert hosted by Sharon Stone kicks off American Heart Month

One of the largest studies on preterm birth finds a maternal biomarker test significantly reduces neonatal morbidities and improves neonatal outcomes

One of the largest studies of its kind finds early intervention with iron delivered intravenously during pregnancy is a safe and effective treatment for anemia

New Case Western Reserve University study identifies key protein’s role in psoriasis

[Press-News.org] Scientists pinpoint protein that could improve small cell lung cancer therapies